Prognostic Value of MRI‐Derived Apparent Diffusion Coefficient in Intermediate‐Risk Prostate Cancer Treated With Definitive Radiotherapy

Study limitation reported by the research below: “No modality-specific drug/treatment brand tags applied as this study involves radiotherapy technique, not a named pharmacologic agent.”